BOUDREAUX GAIL
President and CEO
BOUDREAUX GAIL has filed 3 SEC Form 4 filings (7 transaction rows) across 2 companies, including ELV, TGT, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 17, 2026.
On the most recent filing, BOUDREAUX GAIL is listed as President and CEO at Elevance Health, Inc. Inside the rolling window, BOUDREAUX GAIL reported 1 open-market purchase totaling $1.0M in ELV and no open-market sales.
Companies traded
Other insiders at ELV
Insider Buying
$1.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BOUDREAUX GAIL made?
BOUDREAUX GAIL has filed 3 SEC Form 4 filings (7 transaction rows) across 2 companies, including ELV, TGT since 2026.
Which companies does BOUDREAUX GAIL trade?
BOUDREAUX GAIL has filed SEC Form 4 disclosures for 2 companies, including ELV, TGT.
When was BOUDREAUX GAIL's most recent SEC Form 4 filing?
BOUDREAUX GAIL's most recent SEC Form 4 filing on Tracefour is dated Jul 17, 2026.
What is BOUDREAUX GAIL's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, BOUDREAUX GAIL is listed as President and CEO.
What is BOUDREAUX GAIL's total buy and sell value in the current window?
Inside the rolling retention window, BOUDREAUX GAIL bought $1.0M and sold $0 based on SEC Form 4 filings.
What was BOUDREAUX GAIL's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,725 ELV shares on 2026-07-17, worth $1.0M, per SEC Form 4 filings.